BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 1806604)

  • 21. Counting the nucleolar organizer region-associated proteins is a prognostic clue of malignant melanoma.
    Gambini C; Casazza S; Borgiani L; Canepa M; Rovida S; Rongioletti F; Rebora A
    Arch Dermatol; 1992 Apr; 128(4):487-90. PubMed ID: 1580655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AgNOR counts in conjunctival malignant melanoma lack prognostic value.
    Paridaens AD; Seregard S; Minassian D; Hungerford JL; McCartney AC
    Br J Ophthalmol; 1992 Oct; 76(10):621-3. PubMed ID: 1420045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Re-evaluating silver-stained nucleolar organizer regions (AgNORs) in problematic cutaneous melanocytic lesions: a study with quantitation and pattern analysis.
    Evans AT; Orrell JM; Grant A
    J Pathol; 1991 Sep; 165(1):61-7. PubMed ID: 1955937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Argyrophilic nuclear organizer regions in nasopharyngeal carcinoma and paraneoplastic epithelia.
    Chen M; Lee JC; Lo S; Shen J
    Head Neck; 2003 May; 25(5):395-9. PubMed ID: 12692877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proliferative activity in the malignant cellular blue nevus.
    Pich A; Chiusa L; Margaria E; Aloi F
    Hum Pathol; 1993 Dec; 24(12):1323-9. PubMed ID: 7903955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of the AgNOR method for the differential diagnosis of tumors and for the quantification of non-neoplastic epidermal hyperproliferation in dermatohistology].
    Heinisch G; Barth J
    Zentralbl Pathol; 1994 Mar; 140(1):95-101. PubMed ID: 7515680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleolar organizer regions in iris nevi and melanomas.
    Marcus DM; Mawn LA; Egan KM; Albert DM
    Am J Ophthalmol; 1992 Aug; 114(2):202-7. PubMed ID: 1642296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleolar organizer region count and subjective AgNOR pattern assessment (SAPA) score in skin tumors.
    Khanna AK; Giri AK; Khanna A; Kumar M
    J Surg Oncol; 2001 Dec; 78(4):273-8. PubMed ID: 11745824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of silver binding nucleolar organiser regions (AgNORs) of breast lesions in histological sections and fine needle aspiration smears.
    Basu A; Sanyal S; Bhattacharyya A; Bhattacharyya S; Dasgupta S
    J Indian Med Assoc; 1997 Aug; 95(8):443-7. PubMed ID: 9492450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanin bleaching in argyrophilic staining of AgNORs in pigmented lesions: a morphometric evaluation.
    Li LX; Crotty KA; Palmer AA; Kril JJ; Scolyer RA; McCarthy SW
    Anal Quant Cytol Histol; 2002 Jun; 24(3):166-72. PubMed ID: 12102129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphometric analysis of argyrophilic nucleolar organizer regions (AgNORs) in nasopharyngeal carcinoma.
    Pak MW; To KF; Chen MH; Lo SY; Lam PK; van Hasselt CA
    Head Neck; 2000 Dec; 22(8):760-4. PubMed ID: 11084635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleolar organizer regions as discriminators for the diagnosis of well-differentiated adenocarcinoma of the prostate.
    Schned AR
    Arch Pathol Lab Med; 1993 Oct; 117(10):1000-4. PubMed ID: 8215819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses.
    Wolanski KD; Whitaker D; Shilkin KB; Henderson DW
    Cancer; 1998 Feb; 82(3):583-90. PubMed ID: 9452278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleolar organizer regions argyrophilic associated proteins in cutaneous melanocytic lesions.
    Reis JP; Tellechea O; Baptista AP
    Dermatologica; 1991; 183(2):136-8. PubMed ID: 1743375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of nucleolar organizer regions in tumours of the jaw bones.
    Afolabi OC; Odukoya O; Arole G; Banjo AF
    Niger Postgrad Med J; 2001 Mar; 8(1):7-11. PubMed ID: 11487776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleolar organiser regions in iris melanocytic tumours: an accurate predictor?
    Deuble K; McCartney A
    Eye (Lond); 1990; 4 ( Pt 5)():743-50. PubMed ID: 1704315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell proliferation in intracranial tumours: selective silver staining of nucleolar organizer regions (AgNORs). Application to surgical and experimental neuro-oncology.
    Plate KH; Rüschoff J; Mennel HD
    Neuropathol Appl Neurobiol; 1991 Apr; 17(2):121-32. PubMed ID: 1713308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphometry and digital AgNOR analysis in cytological imprints of benign, borderline and malignant serous ovarian tumours.
    Stemberger-Papić S; Stanković T; Vrdoljak-Mozetic D; Versa-Ostojić D; Krasević M; Stifter S; Audy-Jurković S
    Cytopathology; 2006 Dec; 17(6):382-9. PubMed ID: 17168922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions.
    Tuccari G; Giuffrè G; Lentini M; Batolo D; Catalano A
    Am J Dermatopathol; 2004 Apr; 26(2):171-2; author reply 172-3. PubMed ID: 15024201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.